The Effect of Mandala Coloring, Sleep Quality, Anxiety With Premenstrual Syndrome
The Effect of Mandala Coloring on Sleep Quality and Anxiety Levels in Students With Premenstrual Syndrome
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Premenstrual syndrome (PMS) is a common condition among women of reproductive age, characterized by physical, psychological, and behavioral symptoms that may negatively affect quality of life, social and occupational functioning, sleep, and psychological well-being. Previous studies have demonstrated that PMS is associated with reduced sleep quality and increased anxiety. Non-pharmacological approaches, including art-based interventions, have recently gained attention as supportive strategies for managing PMS-related symptoms. Mandala coloring is a simple, accessible, and low-cost activity that does not require specific artistic skills and has been associated with reduced anxiety, stress, and psychological distress in previous studies.
Although previous research has examined the relationship between PMS, sleep quality, and anxiety, and other studies have investigated the potential benefits of art-based interventions, there is limited evidence regarding the direct effects of mandala coloring on sleep quality and anxiety among women with PMS. Therefore, this clinical trial aims to evaluate the effect of a structured mandala coloring intervention on sleep quality and anxiety levels in women experiencing PMS. The findings may provide evidence for a simple, accessible, and non-pharmacological approach that could support the management of PMS and contribute to women's health care.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: AYCA KIRCA, Phd
- Phone Number: 05392684185
- Email: aycasolt@hotmail.com
Study Locations
-
-
-
Kırklareli, Turkey (Türkiye)
- Kırklareli University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Female students aged 18 and older
- Scoring 45 or higher on the Premenstrual Syndrome Scale
- Scoring 36 or higher on the State-Trait Anxiety Inventory (STAI)
- Scoring 5 or higher on the Pittsburgh Sleep Quality Index (PSQI)
- Having a regular menstrual cycle (21-35 days)
- Volunteering to participate in the study
- Fully completing the survey and scale forms
Exclusion Criteria:
- Not wishing to continue participating in the study
- Having any condition that hinders communication (such as impairments in hearing, speech, or comprehension)
- Having a gynecological condition (e.g., abnormal uterine bleeding, uterine fibroids, ovarian cysts, undergoing hormonal therapy)
- Having a chronic or physical illness
- Having a psychological disorder
- Undergoing psychiatric treatment (pharmacotherapy or psychotherapy)
- Using pharmacological or non-pharmacological methods to alleviate premenstrual symptoms (e.g., oral contraceptives, acupressure, homeopathy, yoga)
- Having a sleep-related issue and receiving treatment for it
- Individuals who exercise regularly
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mandala coloring group
Participants in the intervention group will perform mandala coloring twice weekly for 20-30 minutes per session during the luteal phase of each menstrual cycle for three consecutive menstrual cycles. The intervention will begin approximately 14 days before the expected onset of menstruation and will be performed at a time of day chosen by the participant. Mandala templates and colored pencils will be provided by the researcher. Participants will send a brief message to the researcher before each session and share a photograph of the completed mandala afterward. Reminder messages will be sent twice weekly to support adherence. All of the three-cycle intervention period, participants will complete the Premenstrual Syndrome Scale (PMSS), Pittsburgh Sleep Quality Index (PSQI), and State-Trait Anxiety Inventory (STAI) through an online questionnaire, requiring approximately 30-40 minutes. |
A mandala coloring intervention will be administered to individuals with PMS to evaluate its effects on anxiety reduction and sleep quality improvement.
|
|
No Intervention: Control group
Participants in the control group will not receive any mandala coloring intervention and will be asked to maintain their usual routines without initiating any pharmacological or non-pharmacological intervention aimed at reducing PMS symptoms. Their use of any PMS-related interventions will be monitored twice weekly by telephone throughout the three menstrual cycles. Participants in either group who initiate a pharmacological or non-pharmacological intervention for PMS symptoms during the study will be excluded. All of the of the three-cycle study period, participants will complete the Premenstrual Syndrome Scale (PMSS), Pittsburgh Sleep Quality Index (PSQI), and State-Trait Anxiety Inventory (STAI) through an online questionnaire, requiring approximately 30-40 minutes. After completion of the study, participants will be informed about the mandala coloring intervention and those interested will be offered the opportunity to participate individually. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Social demographic form
Time Frame: between 2 to 4 weeks
|
This form includes questions regarding women's sociodemographic characteristics, menstrual cycles, the presence of chronic diseases, menstrual symptoms, gynecological conditions, whether they have received prior education about menstruation, and whether they use pharmacological or non-pharmacological methods to alleviate premenstrual syndrome.
|
between 2 to 4 weeks
|
|
Premenstrual Syndrome Scale
Time Frame: between 2 to 12 weeks
|
Premenstrual Syndrome Scale (PMSS) is a 44-item, five-point Likert scale used to assess the severity of physical, emotional, and behavioral symptoms experienced before menstruation.
Total scores range from 44 to 220, with higher scores indicating greater PMS symptom severity.
A score above 50% of the maximum possible score (≥110) is considered indicative of PMS.
|
between 2 to 12 weeks
|
|
State-Trait Scale (STAI-1, STAI-2)
Time Frame: between 2 to 12 weeks
|
State-Trait Anxiety Inventory (STAI) is used to assess individuals' state anxiety (temporary anxiety) and trait anxiety (general tendency toward anxiety).
It consists of two 20-item subscales, each scored on a four-point Likert scale.
Total scores for each subscale range from 20 to 80, with higher scores indicating higher anxiety levels.
|
between 2 to 12 weeks
|
|
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: between 2 to 12 weeks
|
Pittsburgh Sleep Quality Index (PSQI) is a self-report instrument used to assess sleep quality and sleep disturbances over the previous month.
It consists of 19 items covering seven components of sleep quality.
Each component is scored from 0 to 3, with a total score ranging from 0 to 21.
Higher scores indicate poorer sleep quality, and a total score of ≥5 indicates poor sleep quality.
|
between 2 to 12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: AYCA KIRCA, Phd, Kırklareli University
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KırklareliAS-16
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.